Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC

被引：4
|
作者：
Alzghoul, Bashar [1 ]
Meena, Nikhil [1 ,2 ]
机构：
[1] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Div Pulm & Crit Care Med, Little Rock, AR 72205 USA
来源：
RESPIRATORY MEDICINE CASE REPORTS | 2016年 / 18卷
关键词：
Bronchoscopy; Lung cancer; Chemo-radiation; Tracheo-pulmonary fistula;
D O I：
10.1016/j.rmcr.2016.03.007
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Non-Small Cell Cancer (NSCLC) are frequently diagnosed at a later stage [1]. Treatment involves chemotherapy and radiation, either sequentially or concurrently [2]. Concurrent therapy is more efficacious but also associated with more complications [4-6]. We present a rare care of trachea-pulmonary fistula formation after concurrent chemo and radiation in a patient with Squamous Cell Cancer (SCC). (C) 2016 The Authors. Published by Elsevier Ltd.
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [41] Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
    Floersch, Benedikt
    Taugner, Julian
    Kaesmann, Lukas
    Kenndoff, Saskia
    Guggenberger, Julian
    Tufman, Amanda
    Reinmuth, Niels
    Duell, Thomas
    Belka, Claus
    Eze, Chukwuka
    Manapov, Farkhad
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3267 - 3276
  • [42] A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
    Casal Rubio, J.
    Firvida-Perez, J. L.
    Lazaro-Quintela, M.
    Baron-Duarte, F. J.
    Alonso-Jaudenes, G.
    Santome, L.
    Afonso-Afonso, F. J.
    Amenedo, M.
    Huidobro, G.
    Campos-Balea, B.
    Lopez-Vazquez, M. D.
    Vazquez, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 451 - 457
  • [43] Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer
    Solomon, B
    Ball, DL
    Richardson, G
    Smith, JG
    Millward, M
    MacManus, M
    Michael, M
    Wirth, A
    O'Kane, C
    Muceniekas, L
    Ryan, G
    Rischin, D
    LUNG CANCER, 2003, 41 (03) : 353 - 361
  • [44] Acute Radiation Esophagitis Caused by High-dose Involved Field Radiotherapy with Concurrent Cisplatin and Vinorelbine for Stage III Non-small Cell Lung Cancer
    Kuroda, Yuuki
    Sekine, Ikuo
    Sumi, Minako
    Sekii, Shuhei
    Takahashi, Kana
    Inaba, Koji
    Horinouchi, Hidehito
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kubota, Kaoru
    Murakami, Naoya
    Morota, Madoka
    Mayahara, Hiroshi
    Ito, Yoshinori
    Tamura, Tomohide
    Nemoto, Kenji
    Itami, Jun
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013, 12 (04) : 333 - 339
  • [45] Three-dimensional conformal radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: protocol for a systematic review and meta-analysis
    Huang, Xiongfeng
    Chen, Qiao
    Ren, Yuxi
    Zhu, Jingshu
    Xu, Lu
    Huang, Shenghe
    Li, Weijuan
    Xu, Jianfeng
    BMJ OPEN, 2024, 14 (11):
  • [46] Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study
    Tsukita, Yoko
    Yamamoto, Takaya
    Mayahara, Hiroshi
    Hata, Akito
    Takeda, Yuichiro
    Nakayama, Hidetsugu
    Tanaka, Satoshi
    Uchida, Junji
    Usui, Kazuhiro
    Toyoda, Tatsuya
    Tamiya, Motohiro
    Morimoto, Masahiro
    Oya, Yuko
    Kodaira, Takeshi
    Miyauchi, Eisaku
    Jingu, Keiichi
    Sugiura, Hisatoshi
    RADIOTHERAPY AND ONCOLOGY, 2021, 160 : 266 - 272
  • [47] Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18
    Choi, Dae-Ho
    Kim, Miso
    Kim, Young Saing
    Park, Keon Uk
    Cho, Jang Ho
    Kim, Hongsik
    Lee, Ki Hyeong
    Ahn, Heejoon
    Kim, Il-Hwan
    Lee, Kyung-Hee
    Lee, Gyeong-Won
    Yi, Seong Yoon
    Ahn, Beung chul
    Lee, Min-Young
    Jung, Hyun Ae
    Park, Sehhoon
    Sun, Jong-Mu
    Ahn, Jin Seok
    Lee, Se-Hoon
    Ahn, Myung-Ju
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (12):
  • [48] A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer
    Center, Brian
    Petty, William Jeffrey
    Ayala, Diandra
    Hinson, William H.
    Lovato, James
    Capellari, James
    Oaks, Timothy
    Miller, Antonius A.
    Blackstock, Arthur William
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) : 69 - 74
  • [49] Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial
    Filippi, Andrea Riccardo
    Agustoni, Francesco
    Arcangeli, Stefano
    Cortinovis, Diego
    Ferrari, Alessandra
    Cicognini, Daniela
    Saddi, Jessica
    Klersy, Catherine
    Pedrazzoli, Paolo
    Malapelle, Umberto
    Grossi, Francesco
    CLINICAL LUNG CANCER, 2023, 24 (03) : E122 - E125
  • [50] High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer
    Zhao, Qian
    Liu, Ming
    Wang, Zhongtang
    Huang, Wei
    Li, X. Allen
    Zhou, Tao
    Zhang, Jian
    Zhang, Zicheng
    Wang, Qiang
    Yu, Shuzeng
    Han, Dan
    Sun, Hongfu
    Li, Hongsheng
    Lin, Haiqun
    Li, Baosheng
    RADIOTHERAPY AND ONCOLOGY, 2020, 145 : 7 - 12
12345